Spring til hovednavigation Spring til søgning Spring til hovedindhold

Direct intramyocardial mesenchymal stromal cell injections in patients with severe refractory angina - one year follow-up

55 Citationer (Scopus)

Abstract

Aims: In patients with stable coronary artery disease (CAD) and refractory angina we performed direct intra-myocardial injections of autologous mesenchymal stromal cells (MSCs) and followed the safety and efficacy of the treatment for 12 months. Methods and Results: A total of 31 patients with stable CAD, moderate to severe angina, normal left ventricular ejection fraction and no further revascularization options, were included. Bone marrow MSCs were isolated and culture expanded for 6 - 8 weeks and then stimulated with vascular endothelial growth factor (VEGF) for one week.The 12 months follow-up demonstrated, that it was safe to culture expand MSCs and use the cells for clinical treatment. The patients maximal metabolic equivalent (MET) during exercise increased from 4.23 MET at baseline to 4.72 MET at 12 months follow-up (p
OriginalsprogEngelsk
TidsskriftCell Transplantation
Vol/bind22
Udgave nummer3
Sider (fra-til)521-8
ISSN0963-6897
DOI
StatusUdgivet - 2013

Fingeraftryk

Dyk ned i forskningsemnerne om 'Direct intramyocardial mesenchymal stromal cell injections in patients with severe refractory angina - one year follow-up'. Sammen danner de et unikt fingeraftryk.

Citationsformater